| P50 | author | Gene B Hubbard | Q118907079 |
| P2093 | author name string | Ahmed Sabbah | |
| | Santanu Bose | |
| | Yuji Ikeno | |
| | Bandana Chatterjee | |
| | Ibtissam Echchgadda | |
| | Te-Hung Chang | |
| | Imad Bakri | |
| P2860 | cites work | Activation of innate immune antiviral responses by Nod2 | Q24646833 |
| | Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei | Q27860728 |
| | How cells respond to interferons | Q27861006 |
| | Rapid and automated tetrazolium-based colorimetric assay for the detection of anti-HIV compounds | Q28339318 |
| | Anticancer oncolytic activity of respiratory syncytial virus | Q33619829 |
| | Exploiting tumor-specific defects in the interferon pathway with a previously unknown oncolytic virus | Q33908950 |
| | Activity and regulation of alpha interferon in respiratory syncytial virus and human metapneumovirus experimental infections | Q33911955 |
| | Catabolic mediators of cancer cachexia. | Q34015136 |
| | Sensitivity of prostate tumors to wild type and M protein mutant vesicular stomatitis viruses | Q34365292 |
| | Genomic strategy for targeting therapy in castration-resistant prostate cancer | Q34605452 |
| | VSV-tumor selective replication and protein translation | Q34651274 |
| | Innate immune response against nonsegmented negative strand RNA viruses | Q35294156 |
| | The role of the androgen receptor in the development of prostatic hyperplasia and prostate cancer | Q35584838 |
| | Targeting the androgen receptor: improving outcomes for castration-resistant prostate cancer | Q35888364 |
| | Temporal activation of NF-kappaB regulates an interferon-independent innate antiviral response against cytoplasmic RNA viruses | Q35978609 |
| | Recent progress in the battle between oncolytic viruses and tumours | Q36315580 |
| | Type 1 interferons and the virus-host relationship: a lesson in détente . | Q36475884 |
| | Oncolytic viruses: what's next? | Q36754435 |
| | Role of human beta-defensin-2 during tumor necrosis factor-alpha/NF-kappaB-mediated innate antiviral response against human respiratory syncytial virus | Q36825544 |
| | Myxoma virus and oncolytic virotherapy: a new biologic weapon in the war against cancer | Q36922264 |
| | Early steps of the virus replication cycle are inhibited in prostate cancer cells resistant to oncolytic vesicular stomatitis virus | Q36994589 |
| | Androgen receptor regulates a distinct transcription program in androgen-independent prostate cancer | Q37305014 |
| | Engineering oncolytic viruses to exploit tumor specific defects in innate immune signaling pathways | Q37564490 |
| | Biology of attenuated modified vaccinia virus Ankara recombinant vector in mice: virus fate and activation of B- and T-cell immune responses in comparison with the Western Reserve strain and advantages as a vaccine | Q39589039 |
| | IFN unresponsiveness in LNCaP cells due to the lack of JAK1 gene expression | Q40434320 |
| | Interferon-resistant human melanoma cells are deficient in ISGF3 components, STAT1, STAT2, and p48-ISGF3gamma. | Q41082105 |
| | Induction of type I interferons and interferon-inducible Mx genes during respiratory syncytial virus infection and reinfection in cotton rats. | Q42551081 |
| | Progression to androgen insensitivity in a novel in vitro mouse model for prostate cancer | Q42803485 |
| | Perfluorononanoic acid-induced apoptosis in rat spleen involves oxidative stress and the activation of caspase-independent death pathway | Q43251561 |
| | Multistage carcinogenesis induced by ras and myc oncogenes in a reconstituted organ. | Q53516187 |
| | Urocortin 2 suppresses host resistance to Listeria monocytogenes infection via up-regulation of interleukin-10. | Q53848645 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | oncolytic virus | Q1560099 |
| | prostate neoplasm | Q56014511 |
| P304 | page(s) | 43 | |
| P577 | publication date | 2011-01-28 | |
| P1433 | published in | BMC Cancer | Q326300 |
| P1476 | title | Oncolytic targeting of androgen-sensitive prostate tumor by the respiratory syncytial virus (RSV): consequences of deficient interferon-dependent antiviral defense | |
| P478 | volume | 11 | |